PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-35.35%
Both companies show declining cash positions (-35.35% vs GNPX's -21.42%). Seth Klarman would examine if this reflects broader market conditions or operational challenges.
No Data
No Data available this quarter, please select a different quarter.
-35.35%
Cash + STI yoy ≥ 1.5x GNPX's -21.42%. David Dodd might see it as a strategic cash buffer advantage. Evaluate deployment plans.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
45.32%
Higher Other Current Assets Growth compared to GNPX's zero value, indicating worse performance.
-30.67%
≥ 1.5x GNPX's -17.52%. David Dodd might see a short-term liquidity advantage or potential underutilized capital.
-13.90%
Below half GNPX's 88.04%. Michael Burry sees potential underinvestment risk unless there's a valid reason (asset-light model).
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.03%
Less than half of GNPX's 85.24%. David Dodd sees fewer expansions in non-core assets. Possibly a simpler focus.
-10.42%
Below half of GNPX's 21.37%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
-28.48%
≥ 1.5x GNPX's -13.13%. David Dodd notes a larger balance sheet expansion. Confirm it's not overleveraged.
-10.38%
1.25-1.5x GNPX's -8.17%. Martin Whitman sees potential reliance on supplier financing. Verify liquidity.
1404.09%
Higher Short-Term Debt Growth compared to GNPX's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
10.38%
Higher Deferred Revenue (Current) Growth compared to GNPX's zero value, indicating better performance.
No Data
No Data available this quarter, please select a different quarter.
-3.56%
50-75% of GNPX's -4.94%. Bruce Berkowitz notes the firm keeps current liabilities growth relatively low.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-18.88%
Higher Total Non-Current Liabilities Growth compared to GNPX's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
-5.58%
1.1-1.25x GNPX's -4.94%. Bill Ackman questions if the firm is incurring more total obligations than competitor.
No Data
No Data available this quarter, please select a different quarter.
-2.25%
Below half GNPX's -6.37%. Michael Burry suspects major net losses or high dividends vs. competitor.
-5.49%
Less than half of GNPX's -100.00%. David Dodd sees fewer intangible or market-driven swings than competitor.
No Data
No Data available this quarter, please select a different quarter.
-43.19%
≥ 1.5x GNPX's -14.37%. David Dodd sees stronger capital base growth than competitor.
-28.48%
≥ 1.5x GNPX's -13.13%. David Dodd sees faster overall balance sheet growth than competitor.
No Data
No Data available this quarter, please select a different quarter.
14.13%
50-75% of GNPX's 19.70%. Bruce Berkowitz sees relatively smaller yoy debt additions.
40.09%
Above 1.5x GNPX's 22.45%. Michael Burry sees a major gap in net debt growth. Check coverage and liquidity.